Literature DB >> 10535610

Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia.

O Sanal1, F Ersoy, L Yel, I Tezcan, A Metin, H Ozyürek, S Gariboglu, S Fikrig, A I Berkel, G T Rijkers, B J Zegers.   

Abstract

Various factors seem to be etiologic in the susceptibility to sinopulmonary infections in ataxia-telangiectasia (A-T) patients, i.e., low serum and salivary IgA, low serum IgG2, and even aspiration of saliva. S. pneumoniae is a common pathogen responsible from pulmonary infections and impaired antibody response to polysaccharide antigens is seen in patients with IgG2 and IgA deficiency as well as patients with CVID and WAS. We studied IgG-type antibody production to six pneumococcal serotypes in 29 A-T patients by ELISA before and 3-4 weeks after pneumococcal vaccine. The response was considered positive when the antibody titer was >10 U/ml but weak when the titer was 10-20 U/ml. Twenty-two of 29 (76%) patients did not respond to any of the serotypes, 5 (17%) showed a positive response to one serotype, 1 (3.4%) to two serotypes, and 1 (3.4%) to four serotypes. With conversion to gravimetric units (ng IgG/ml) and >1800 ng/ml (300 ng Ab N/ml) considered a positive response, 5 of 29 (17.2%) patients showed a positive response (300 ng ab N/ml) to two or fewer serotypes. All patients tested produced IgG antibody to tetanus toxoid. Sixteen of 27 (59.3%) patients had low IgG2 and four (14.8%) had low IgG3 levels, while 18 (62.1%) of 29 patients had low serum IgA. No correlation was found either between serum Ig isotype levels and antipolysaccharide antibody response or between susceptibility to infection and antibody production. The mechanism responsible for disturbed antipolysaccharide (TI-2 antigen) antibody production in patients with A-T needs to be investigated. It may provide additional information on the function of the ATM gene product and be helpful in clarifying the role of B cells and contribution of T cells in TI-2 responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535610     DOI: 10.1023/a:1020599810261

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  34 in total

1.  Anti-pneumococcal antibody response in normal subjects: a meta-analysis.

Authors:  E S Go; Z K Ballas
Journal:  J Allergy Clin Immunol       Date:  1996-07       Impact factor: 10.793

2.  Immunoglobulin E deficiency in ataxia-telangiectasia.

Authors:  A J Ammann; W A Cain; K Ishizaka; R Hong; R A Good
Journal:  N Engl J Med       Date:  1969-08-28       Impact factor: 91.245

3.  Serum immunoglobulin G subclass values in healthy Turkish children and adults.

Authors:  A I Berkel; I Tezcan; F Ersoy; O Sanal
Journal:  Turk J Pediatr       Date:  1994 Jul-Sep       Impact factor: 0.552

4.  Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.

Authors:  G R Siber; P H Schur; A C Aisenberg; S A Weitzman; G Schiffman
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

5.  Patients with Igg subclass and/or selective antibody deficiency to polysaccharide antigens: initiation of a controlled clinical trial of intravenous immune globulin.

Authors:  A P Knutsen
Journal:  J Allergy Clin Immunol       Date:  1989-10       Impact factor: 10.793

6.  Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia-telangiectasia cells.

Authors:  K K Khanna; J Yan; D Watters; K Hobson; H Beamish; K Spring; Y Shiloh; R A Gatti; M F Lavin
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

Review 7.  Anti-capsular polysaccharide antibody deficiency states.

Authors:  G T Rijkers; L A Sanders; B J Zegers
Journal:  Immunodeficiency       Date:  1993

8.  Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency.

Authors:  D T Umetsu; D M Ambrosino; I Quinti; G R Siber; R S Geha
Journal:  N Engl J Med       Date:  1985-11-14       Impact factor: 91.245

9.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

Authors:  K Savitsky; A Bar-Shira; S Gilad; G Rotman; Y Ziv; L Vanagaite; D A Tagle; S Smith; T Uziel; S Sfez; M Ashkenazi; I Pecker; M Frydman; R Harnik; S R Patanjali; A Simmons; G A Clines; A Sartiel; R A Gatti; L Chessa; O Sanal; M F Lavin; N G Jaspers; A M Taylor; C F Arlett; T Miki; S M Weissman; M Lovett; F S Collins; Y Shiloh
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

10.  Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.

Authors:  H Hidalgo; C Moore; L E Leiva; R U Sorensen
Journal:  Ann Allergy Asthma Immunol       Date:  1996-04       Impact factor: 6.347

View more
  14 in total

Review 1.  The genetic basis of pneumococcal and staphylococcal infections: inborn errors of human TLR and IL-1R immunity.

Authors:  Bertrand Boisson
Journal:  Hum Genet       Date:  2020-01-24       Impact factor: 4.132

Review 2.  Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.

Authors:  Lumin Zhang; Zihai Li; Zhuang Wan; Andrew Kilby; J Michael Kilby; Wei Jiang
Journal:  Vaccine       Date:  2015-06-30       Impact factor: 3.641

3.  Immune deficiency in Ataxia-Telangiectasia: a longitudinal study of 44 patients.

Authors:  C Chopra; G Davies; M Taylor; M Anderson; S Bainbridge; P Tighe; E M McDermott
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

4.  Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia.

Authors:  A Stray-Pedersen; I S Aaberge; A Früh; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

Review 5.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

6.  The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.

Authors:  A Stray-Pedersen; T Jónsson; A Heiberg; C R Lindman; E Widing; I S Aaberge; A L Borresen-Dale; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

7.  Immunodeficiency, radiosensitivity, and the XCIND syndrome.

Authors:  Richard A Gatti; Elena Boder; Robert A Good
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

8.  Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.

Authors:  E R Staples; E M McDermott; A Reiman; P J Byrd; S Ritchie; A M R Taylor; E G Davies
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

9.  Antibody response to a seven-valent pneumococcal conjugated vaccine in patients with ataxia-telangiectasia.

Authors:  Ozden Sanal; Fugen Ersoy; Ilhan Tezcan; Ayse Metin; Tuba Turul; Semra Gariboglu; Leman Yel
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

10.  Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis.

Authors:  C J Harbort; Paulo Vitor Soeiro-Pereira; Horst von Bernuth; Angela M Kaindl; Beatriz Tavares Costa-Carvalho; Antonio Condino-Neto; Janine Reichenbach; Joachim Roesler; Arturo Zychlinsky; Borko Amulic
Journal:  Blood       Date:  2015-10-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.